Is It the Time for Direct Oral Anticoagulants in Bioprosthetic Heart Valves?

Journal Article Is it the time for direct oral anticoagulants in bioprosthetic heart valves? Get access Wael Saade, Wael Saade Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Mariangela Peruzzi, Mariangela Peruzzi Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, ItalyMediterranea Cardiocentro, Naples, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Giuseppe Biondi-Zoccai, Giuseppe Biondi-Zoccai Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyMediterranea Cardiocentro, Naples, Italy Corresponding author. Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy. Tel: +39 340 86 26 829; e-mail: giuseppe.biondizoccai@uniroma1.it (G. Biondi-Zoccai). https://orcid.org/0000-0001-6103-8510 Search for other works by this author on: Oxford Academic PubMed Google Scholar Giacomo Frati Giacomo Frati Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyIRCCS NeuroMed, Pozzilli, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar European Journal of Cardio-Thoracic Surgery, Volume 63, Issue 4, April 2023, ezad113, https://doi.org/10.1093/ejcts/ezad113 Published: 23 March 2023 Article history Received: 16 March 2023 Accepted: 22 March 2023 Published: 23 March 2023 Corrected and typeset: 12 April 2023